Skip to main content

Table 1 Health and medical conditions recommended for cannabis treatment on 179 identified websites and corresponding conclusions from the National Academies 2017 review

From: A content analysis of internet information sources on medical cannabis

Condition Percent NASEM conclusion
Nausea (including from chemotherapy) 26 Conclusive or substantial
Pain 24 (no conclusion)
Epilepsy 23 None or insufficient
Multiple sclerosis 21 Conclusive or substantial
Chronic pain 20 Conclusive or substantial
Anxiety 20 Limited
Appetite loss 19 Limited
Cancer 19 None or insufficient
Glaucoma/Intraocular pressure 15 Ineffective (limited)
Depression 14 Ineffective (limited)
Vomiting (including from chemotherapy) 14 Conclusive or substantial
Chronic Fatigue Syndrome 13 (no conclusion)
Insomnia 13 (no conclusion)
PTSD 13 Limited
Neuropathic pain 11 (no conclusion)
Arthritis (including various forms) 10 (no conclusion)
Inflammation 10 Limited
HIV/AIDS 10 None or insufficient
Muscle spasms 10 (no conclusion)
Drug and alcohol addiction 9 Increased risk (moderate)
  1. Note: NASEM Conclusion indicates determinations by the National Academies of Sciences, Engineering, and Medicine (2017) that there is conclusive or substantial evidence that cannabis or cannabinoids are effective in treatment, conditions for which evidence for effectiveness was limited, conditions with no or insufficient evidence for treatment effectiveness (9%), conditions with evidence for the ineffectiveness of treatment, and conditions with evidence for increased risk due to the use of cannabis